4. Neurology of Anxiety Disorders

1. title
2. tl;dr
3. BSD Pt. 1
4. BSD Pt. 2
5. Biological Mechanisms Pt. 1
6. Biological Mechanisms Pt. 2
7. Risk Factors
8. treatments I
9. treatments II

References*

    1. Generalized Anxiety Disorder: When Worry Gets Out of Control. National Institute of Mental Health (2016).
    2. Locke, A. B., Kirst, N. & Shultz, C. G. Diagnosis and Management of Generalized Anxiety Disorder and Panic Disorder in Adults. American Family Physician (2015).
    3. Pelletier, L., O’Donnell, S., McRae, L. & Grenier, J. The burden of generalized anxiety disorder in Canada. Health Promotion and Chronic Disease Prevention in Canada 37, (2017).
    4. Martin, E. I., Ressier, K. J., Binder, E. & Nemeroff, C. B. The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology. Psychiatric Clinics of North America 32, 549–575 (2009).
    5. Lebow, M. A. & Chen, A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Molecular Psychiatry 21, 450–463 (2016).
    6. Anxiety and Brain. direct (2017).
    7. Gottschalk, M. G. & Domschke, K. Genetics of generalized anxiety disorder and related traits. Dialogues in Clinical Neuroscience 19, 159–168 (2017).
    8. Smoller, J. W. Anxiety Genetics Goes Genomic. The American Journal of Psychiatry 177, 190–194 (2020).
    9. Björkegren, J. L. M., Kovacic, J. C., Dudley, J. T. & Schadt, E. E. Genome-Wide Significant Loci: How Important Are They? Journals of the American College of Cardiology 65, 830–845 (2016).
    10. Aktar, E., Nikolić, M. & Bögels, S. M. Environmental transmission of generalized anxiety disorder from parents to children: worries, experiential avoidance, and intolerance of uncertainty. Dialogues in Clinical Neuroscience 19, 137–147 (2017).
    11. Bystritsky, A., Khalsa, S. S., Cameron, M. E. & Schiffman, J. Current Diagnosis and Treatment of Anxiety Disorders. P & T: A Peer-Reviewed Journal for Formulary Management 38, 41–44 (2013).
    12. Gould, R. A., Otto, M. W., Pollack, M. H. & Yap, L. Cognitive behavioural and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis. Behaviour Therapy 28, 285–305 (1997).
    13. Psychotherapy. CAMH (2021).
    14. Sartori, S. B. & Singewald, N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacology & Therapeutics 204, (2019).

*: We've formatted all references according to Nature format but left the links out. Instead, we've embedded them for your viewing pleasure!